FindTrial
Sign In

A study to assess the effectiveness of patient information booklet in preventing Hand foot syndrome in cancer patients recieving fluorouracil and capecitabine

A study to assess the effectiveness of information booklet on prevention of hand foot syndrome in breast cancer patients receiving fluorouracil and capecitabine

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/06/019519
Enrollment
80
Registered
2019-06-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L988- Other specified disorders of the skin and subcutaneous tissue Health Condition 2: null- Prevention of Hand foot syndrome

Interventions

Intervention1: Provision of information booklet on Hand foot syndrome prevention: Patients receiving 5FU and capecitabine were randomly allocated to experimental and control group with sequentially se

Sponsors

No sponser
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult male or female diagnosed with cancer and were recieving 5FU or capecitabine Who could read Hindi or english.

Exclusion criteria

Exclusion criteria: Who were not willing to participate in the study. Who cannot read Hindi or English.

Design outcomes

Primary

MeasureTime frame
Prevention of Hand foot syndrome Increase in knowledgeTimepoint: 3 weeks after intervention—

Secondary

MeasureTime frame
Association of knowledge with hand foot syndromeTimepoint: at baseline and 21 days after intervention—

Countries

India

Contacts

Public ContactRachel Andrews

College of Nursing AIIMS New Delhi

gaddamrachel@gmail.com9953224917

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026